These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10487797)

  • 41. Use of statin drugs in women.
    LaRosa JC
    J Hypertens Suppl; 2002 May; 20(2):S70-2. PubMed ID: 12183858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.
    Barnhart J; Lewis V; Houghton JL; Charney P
    Womens Health Issues; 2007; 17(2):93-100. PubMed ID: 17403466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosing pulmonary emboli: a critical review for the clinician and radiologist.
    Safriel Y; Hull F
    Yale J Biol Med; 2005 May; 78(3):157-71. PubMed ID: 16464315
    [No Abstract]   [Full Text] [Related]  

  • 44. Emerging concepts on catheter ablation of atrial fibrillation from the tenth annual Boston Atrial Fibrillation Symposium.
    Keane D; Reddy V; Ruskin J;
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):1025-8. PubMed ID: 16174029
    [No Abstract]   [Full Text] [Related]  

  • 45. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era.
    Thompson CA; Kaplan AV; Friedman BJ; Jayne JE; Gerling BR; Niles NW; Hettleman BD; Robb JF
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):25-31. PubMed ID: 16345036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of the Multiple Risk Factor Intervention Trial (MRFIT).
    Russell RP; Lewis C
    Md State Med J; 1984 Jan; 33(1):13-4. PubMed ID: 6700270
    [No Abstract]   [Full Text] [Related]  

  • 47. [Why do countries differ in deaths from ischaemic heart disease?].
    Czepiel A
    Kardiol Pol; 1993 Oct; 39(10):314-5. PubMed ID: 8246359
    [No Abstract]   [Full Text] [Related]  

  • 48. Possibly disappointing results of treatment with gemfibrozil.
    Newman TB
    N Engl J Med; 1993 Jan; 328(2):139-40. PubMed ID: 8416432
    [No Abstract]   [Full Text] [Related]  

  • 49. Heart disease in Europe.
    Lancet; 2013 Jul; 382(9886):2. PubMed ID: 23830328
    [No Abstract]   [Full Text] [Related]  

  • 50. Mass control of coronary risk factors.
    Lancet; 1983 Aug; 2(8346):406-7. PubMed ID: 6135903
    [No Abstract]   [Full Text] [Related]  

  • 51. Targeting coronary risk factor control.
    Lancet; 1983 Jul; 2(8343):213-14. PubMed ID: 6135041
    [No Abstract]   [Full Text] [Related]  

  • 52. Should we not forget about mass control of coronary risk factors?
    Oliver MF
    Lancet; 1983 Jul; 2(8340):37-8. PubMed ID: 6134896
    [No Abstract]   [Full Text] [Related]  

  • 53. [The practice of sports, a treatment for coronary disease].
    Letac B; Richard C; Cribier A; Champoud O
    Rev Prat; 1981 May; 31(25):1795-8, 1801-2, 1805-7. PubMed ID: 7233035
    [No Abstract]   [Full Text] [Related]  

  • 54. Variations between countries in invasive cardiac procedures.
    James MA
    Lancet; 1998 Oct; 352(9138):1469; author reply 1470-1. PubMed ID: 9808013
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle].
    Savonitto S; Klugmann S
    Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. U.S. statin guidelines: expensive but not necessarily effective.
    Barry HC; Hoffman JR
    Am Fam Physician; 2007 May; 75(10):1453-4, 1456. PubMed ID: 17555139
    [No Abstract]   [Full Text] [Related]  

  • 58. The rudimentary phase of personalised medicine: coronary risk scores.
    Topol EJ; Lauer MS
    Lancet; 2003 Nov; 362(9398):1776-7. PubMed ID: 14654312
    [No Abstract]   [Full Text] [Related]  

  • 59. Potential to reduce death by cardiological treatment.
    Rosolova H; Simon J
    Eur Heart J; 1999 Oct; 20(19):1376-7. PubMed ID: 10487797
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.